Phibro Animal Health | PAHC - Capital Ordinário





Capital Ordinário Alterar Data
Align Technology USD 71.62M 133K 2026-03
ANI Pharmaceuticals USD 22.49M 760K 2025-12
Aurora Cannabis CAD 58.95M 2.24M 2026-03
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Canopy Growth CAD 422.07M 53.78M 2026-03
Corcept Therapeutics USD 107.33M 1.36M 2026-03
Eli Lilly USD 943.5M 3.33M 2026-03
Henry Schein USD 114.42M 1.35M 2026-03
Idexx Laboratories USD 79.24M 611K 2026-03
Knight Therapeutics CAD 99.68M 24.66K 2025-09
Merck USD 2.47B 12.72M 2025-12
Nektar Therapeutics USD 20.38M 20.36M 2025-12
Pacira USD 39.31M 1.81M 2026-03
Phibro Animal Health USD 40.48M 0 2025-12
Prestige Brands USD 47.32M 765K 2025-12
Supernus Pharmaceuticals USD 58.04M 582K 2026-03
Zoetis USD 420.35M 4.58M 2026-03